| 前收盘价格 | 21.44 |
| 收盘价格 | 21.31 |
| 成交量 | 686,803 |
| 平均成交量 (3个月) | 1,199,274 |
| 市值 | 1,586,408,576 |
| 价格/销量 (P/S) | 6.47 |
| 股市价格/股市净资产 (P/B) | 4.02 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 |
| 营业毛利率 | -83.39% |
| 营业利益率 (TTM) | -85.45% |
| 稀释每股收益 (EPS TTM) | -2.63 |
| 季度收入增长率 (YOY) | 62.70% |
| 总债务/股东权益 (D/E MRQ) | 31.15% |
| 流动比率 (MRQ) | 3.45 |
| 营业现金流 (OCF TTM) | 25.97 M |
| 杠杆自由现金流 (LFCF TTM) | -17.73 M |
| 资产报酬率 (ROA TTM) | -16.27% |
| 股东权益报酬率 (ROE TTM) | -43.33% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (US) | 看跌 | 混合的 |
| Health Information Services (全球的) | 看跌 | 混合的 | |
| 股票 | Schrodinger, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.3
| 分析师共识 | 1.5 |
| 内部交易活动 | 1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.30 |
|
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Core |
| 内部持股比例 | 2.58% |
| 机构持股比例 | 101.84% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Gates Foundation Trust | 31 Mar 2025 | 6,981,664 |
| 52周波幅 | ||
| 中 | 32.00 (48.01%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Keybanc | 16 Apr 2025 | 32.00 (48.01%) | 购买 | 25.21 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CHODAKEWITZ JEFFREY | 21.05 | - | 5,997 | 126,237 |
| FRIESNER RICHARD | 21.05 | - | 5,997 | 126,237 |
| GINSBERG GARY L | 21.05 | - | 5,997 | 126,237 |
| KAPELLER-LIBERMANN ROSANA | 21.05 | - | 5,997 | 126,237 |
| LYNTON MICHAEL | 21.05 | - | 5,997 | 126,237 |
| OBEROI ARUN | 21.05 | - | 5,997 | 126,237 |
| SENDER GARY | 21.05 | - | 5,997 | 126,237 |
| THORNBERRY NANCY | 21.05 | - | 5,997 | 126,237 |
| VAN KRALINGEN BRIDGET A | 21.05 | - | 1,499 | 31,554 |
| 累积净数量 | 49,475 | |||
| 累积净值 ($) | 1,041,449 | |||
| 累积平均购买 ($) | 21.05 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| FRIESNER RICHARD | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| OBEROI ARUN | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| GINSBERG GARY L | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| KAPELLER-LIBERMANN ROSANA | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| THORNBERRY NANCY | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| VAN KRALINGEN BRIDGET A | 董事 | 18 Jun 2025 | 获得 (+) | 1,499 | 21.05 | 31,554 |
| LYNTON MICHAEL | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| SENDER GARY | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
| CHODAKEWITZ JEFFREY | 董事 | 18 Jun 2025 | 获得 (+) | 5,997 | 21.05 | 126,237 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合